Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus

Aim The aim of this study is to clarify the value of serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein (WFA+‐M2BP) for predicting hepatocellular carcinoma (HCC) in chronic hepatitis C patients who achieved sustained virologic response (SVR) by therapy with interferon‐free, direct‐a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hepatology research 2018-12, Vol.48 (13), p.1131-1139
Hauptverfasser: Yasui, Yutaka, Kurosaki, Masayuki, Komiyama, Yasuyuki, Takada, Hitomi, Tamaki, Nobuharu, Watakabe, Keiya, Okada, Mao, Wang, Wan, Shimizu, Takao, Kubota, Yohei, Higuchi, Mayu, Takaura, Kenta, Tsuchiya, Kaoru, Nakanishi, Hiroyuki, Takahashi, Yuka, Itakura, Jun, Enomoto, Nobuyuki, Izumi, Namiki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1139
container_issue 13
container_start_page 1131
container_title Hepatology research
container_volume 48
creator Yasui, Yutaka
Kurosaki, Masayuki
Komiyama, Yasuyuki
Takada, Hitomi
Tamaki, Nobuharu
Watakabe, Keiya
Okada, Mao
Wang, Wan
Shimizu, Takao
Kubota, Yohei
Higuchi, Mayu
Takaura, Kenta
Tsuchiya, Kaoru
Nakanishi, Hiroyuki
Takahashi, Yuka
Itakura, Jun
Enomoto, Nobuyuki
Izumi, Namiki
description Aim The aim of this study is to clarify the value of serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein (WFA+‐M2BP) for predicting hepatocellular carcinoma (HCC) in chronic hepatitis C patients who achieved sustained virologic response (SVR) by therapy with interferon‐free, direct‐acting antivirals (DAAs). Methods This is a retrospective cohort study that included 567 patients who underwent antiviral therapy with an interferon‐free DAA regimen and achieved SVR. Serum WFA+‐M2BP was measured after SVR. Factors predictive of HCC occurrence and recurrence were analyzed in the patients after stratification by previous treatment history of HCC. Results Among 518 patients who had no history of HCC, 13 developed HCC. Post‐SVR WFA+‐M2BP ≥1.75 cut‐off index (C.O.I., P 
doi_str_mv 10.1111/hepr.13233
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2073323287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2158394851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4473-fa3334c5ca0b36174d53867e17de5f96697c8bcd022b157dd6d8f723643f39213</originalsourceid><addsrcrecordid>eNp9kU2KFTEUhQtR7B-duAAJOBGh2vxUVeoN5dHaQosiis6KVHLzvE29pMxPy5u5BFfWi3AlpqzWgQMzuQn5OOckp6oeMXrGynr-BeZwxgQX4k51zHrJayqaz3fLXvRd3YmmO6pOYryilEnKm_vVkaBU0AIeVzefMCYIqIidfMAxO6OI2u2mnNCh-_n9x-wjJrwG8kbpcuRkRGfQ7cgcfAJ0ZYJBnSIBFaYD8VrnEMBpIN6Skk0lr2Ga8qQC0SpodH5fPGyxJTHHpNCBIdcY_OR3qEmAOHsXgYwHYjCATsVW6bR4KleiYFBTJNaHVb2ki2S7COT4oLpnyyU8vJ2n1ceX5x-2F_Xl21evty8ua900UtRWCSEa3WpFR9Ex2Zi2fJUEJg20dtN1G6n7URvK-chaaUxneiu56BphxYYzcVo9XXXLJ3zNENOwx7i8UjnwOQ6cSlEK4b0s6JN_0CufgyvpBs7aXmyavl0En62UDj7GAHaYA-5VOAyMDkvLw9Ly8LvlAj--lczjHsxf9E-tBWAr8A0nOPxHarg4f_d-Ff0F27i6nw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2158394851</pqid></control><display><type>article</type><title>Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yasui, Yutaka ; Kurosaki, Masayuki ; Komiyama, Yasuyuki ; Takada, Hitomi ; Tamaki, Nobuharu ; Watakabe, Keiya ; Okada, Mao ; Wang, Wan ; Shimizu, Takao ; Kubota, Yohei ; Higuchi, Mayu ; Takaura, Kenta ; Tsuchiya, Kaoru ; Nakanishi, Hiroyuki ; Takahashi, Yuka ; Itakura, Jun ; Enomoto, Nobuyuki ; Izumi, Namiki</creator><creatorcontrib>Yasui, Yutaka ; Kurosaki, Masayuki ; Komiyama, Yasuyuki ; Takada, Hitomi ; Tamaki, Nobuharu ; Watakabe, Keiya ; Okada, Mao ; Wang, Wan ; Shimizu, Takao ; Kubota, Yohei ; Higuchi, Mayu ; Takaura, Kenta ; Tsuchiya, Kaoru ; Nakanishi, Hiroyuki ; Takahashi, Yuka ; Itakura, Jun ; Enomoto, Nobuyuki ; Izumi, Namiki</creatorcontrib><description>Aim The aim of this study is to clarify the value of serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein (WFA+‐M2BP) for predicting hepatocellular carcinoma (HCC) in chronic hepatitis C patients who achieved sustained virologic response (SVR) by therapy with interferon‐free, direct‐acting antivirals (DAAs). Methods This is a retrospective cohort study that included 567 patients who underwent antiviral therapy with an interferon‐free DAA regimen and achieved SVR. Serum WFA+‐M2BP was measured after SVR. Factors predictive of HCC occurrence and recurrence were analyzed in the patients after stratification by previous treatment history of HCC. Results Among 518 patients who had no history of HCC, 13 developed HCC. Post‐SVR WFA+‐M2BP ≥1.75 cut‐off index (C.O.I., P &lt; 0.001) and α‐fetoprotein (AFP) level ≥6 ng/mL (P = 0.01) were significant predictors of HCC development. Multivariate analysis showed that post‐SVR WFA+‐M2BP ≥1.75 C.O.I. was an independent factor significantly associated with the development of HCC (hazard ratio [HR] 6.0; 95% confidence interval (CI), 1.8–19.4; P = 0.003). Among 49 patients who had a previous history of HCC, 22 had recurrence after SVR. Post‐SVR AFP ≥6 ng/mL was the only factor associated with recurrence‐free survival (HR 3.1; 95% CI, 1.3–7.5; P = 0.01). Conclusions Post‐SVR WFA+‐M2BP is a predictive factor for the development of HCC in patients with no previous HCC history and treated with DAAs. Post‐SVR AFP was predictive for HCC recurrence after DAA therapy.</description><identifier>ISSN: 1386-6346</identifier><identifier>EISSN: 1872-034X</identifier><identifier>DOI: 10.1111/hepr.13233</identifier><identifier>PMID: 30030872</identifier><language>eng</language><publisher>Netherlands: Wiley Subscription Services, Inc</publisher><subject>alpha‐fetoprotein ; Antiviral agents ; chronic hepatitis C ; Hepatitis ; Hepatitis C ; Hepatocellular carcinoma ; Interferon ; Liver cancer ; Multivariate analysis ; Patients ; Wisteria floribunda ; Wisteria floribunda agglutinin‐positive Mac‐2 binding protein</subject><ispartof>Hepatology research, 2018-12, Vol.48 (13), p.1131-1139</ispartof><rights>2018 The Japan Society of Hepatology</rights><rights>2018 The Japan Society of Hepatology.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4473-fa3334c5ca0b36174d53867e17de5f96697c8bcd022b157dd6d8f723643f39213</citedby><cites>FETCH-LOGICAL-c4473-fa3334c5ca0b36174d53867e17de5f96697c8bcd022b157dd6d8f723643f39213</cites><orcidid>0000-0002-6117-4990</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fhepr.13233$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fhepr.13233$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30030872$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yasui, Yutaka</creatorcontrib><creatorcontrib>Kurosaki, Masayuki</creatorcontrib><creatorcontrib>Komiyama, Yasuyuki</creatorcontrib><creatorcontrib>Takada, Hitomi</creatorcontrib><creatorcontrib>Tamaki, Nobuharu</creatorcontrib><creatorcontrib>Watakabe, Keiya</creatorcontrib><creatorcontrib>Okada, Mao</creatorcontrib><creatorcontrib>Wang, Wan</creatorcontrib><creatorcontrib>Shimizu, Takao</creatorcontrib><creatorcontrib>Kubota, Yohei</creatorcontrib><creatorcontrib>Higuchi, Mayu</creatorcontrib><creatorcontrib>Takaura, Kenta</creatorcontrib><creatorcontrib>Tsuchiya, Kaoru</creatorcontrib><creatorcontrib>Nakanishi, Hiroyuki</creatorcontrib><creatorcontrib>Takahashi, Yuka</creatorcontrib><creatorcontrib>Itakura, Jun</creatorcontrib><creatorcontrib>Enomoto, Nobuyuki</creatorcontrib><creatorcontrib>Izumi, Namiki</creatorcontrib><title>Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus</title><title>Hepatology research</title><addtitle>Hepatol Res</addtitle><description>Aim The aim of this study is to clarify the value of serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein (WFA+‐M2BP) for predicting hepatocellular carcinoma (HCC) in chronic hepatitis C patients who achieved sustained virologic response (SVR) by therapy with interferon‐free, direct‐acting antivirals (DAAs). Methods This is a retrospective cohort study that included 567 patients who underwent antiviral therapy with an interferon‐free DAA regimen and achieved SVR. Serum WFA+‐M2BP was measured after SVR. Factors predictive of HCC occurrence and recurrence were analyzed in the patients after stratification by previous treatment history of HCC. Results Among 518 patients who had no history of HCC, 13 developed HCC. Post‐SVR WFA+‐M2BP ≥1.75 cut‐off index (C.O.I., P &lt; 0.001) and α‐fetoprotein (AFP) level ≥6 ng/mL (P = 0.01) were significant predictors of HCC development. Multivariate analysis showed that post‐SVR WFA+‐M2BP ≥1.75 C.O.I. was an independent factor significantly associated with the development of HCC (hazard ratio [HR] 6.0; 95% confidence interval (CI), 1.8–19.4; P = 0.003). Among 49 patients who had a previous history of HCC, 22 had recurrence after SVR. Post‐SVR AFP ≥6 ng/mL was the only factor associated with recurrence‐free survival (HR 3.1; 95% CI, 1.3–7.5; P = 0.01). Conclusions Post‐SVR WFA+‐M2BP is a predictive factor for the development of HCC in patients with no previous HCC history and treated with DAAs. Post‐SVR AFP was predictive for HCC recurrence after DAA therapy.</description><subject>alpha‐fetoprotein</subject><subject>Antiviral agents</subject><subject>chronic hepatitis C</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>Hepatocellular carcinoma</subject><subject>Interferon</subject><subject>Liver cancer</subject><subject>Multivariate analysis</subject><subject>Patients</subject><subject>Wisteria floribunda</subject><subject>Wisteria floribunda agglutinin‐positive Mac‐2 binding protein</subject><issn>1386-6346</issn><issn>1872-034X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kU2KFTEUhQtR7B-duAAJOBGh2vxUVeoN5dHaQosiis6KVHLzvE29pMxPy5u5BFfWi3AlpqzWgQMzuQn5OOckp6oeMXrGynr-BeZwxgQX4k51zHrJayqaz3fLXvRd3YmmO6pOYryilEnKm_vVkaBU0AIeVzefMCYIqIidfMAxO6OI2u2mnNCh-_n9x-wjJrwG8kbpcuRkRGfQ7cgcfAJ0ZYJBnSIBFaYD8VrnEMBpIN6Skk0lr2Ga8qQC0SpodH5fPGyxJTHHpNCBIdcY_OR3qEmAOHsXgYwHYjCATsVW6bR4KleiYFBTJNaHVb2ki2S7COT4oLpnyyU8vJ2n1ceX5x-2F_Xl21evty8ua900UtRWCSEa3WpFR9Ex2Zi2fJUEJg20dtN1G6n7URvK-chaaUxneiu56BphxYYzcVo9XXXLJ3zNENOwx7i8UjnwOQ6cSlEK4b0s6JN_0CufgyvpBs7aXmyavl0En62UDj7GAHaYA-5VOAyMDkvLw9Ly8LvlAj--lczjHsxf9E-tBWAr8A0nOPxHarg4f_d-Ff0F27i6nw</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Yasui, Yutaka</creator><creator>Kurosaki, Masayuki</creator><creator>Komiyama, Yasuyuki</creator><creator>Takada, Hitomi</creator><creator>Tamaki, Nobuharu</creator><creator>Watakabe, Keiya</creator><creator>Okada, Mao</creator><creator>Wang, Wan</creator><creator>Shimizu, Takao</creator><creator>Kubota, Yohei</creator><creator>Higuchi, Mayu</creator><creator>Takaura, Kenta</creator><creator>Tsuchiya, Kaoru</creator><creator>Nakanishi, Hiroyuki</creator><creator>Takahashi, Yuka</creator><creator>Itakura, Jun</creator><creator>Enomoto, Nobuyuki</creator><creator>Izumi, Namiki</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6117-4990</orcidid></search><sort><creationdate>201812</creationdate><title>Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus</title><author>Yasui, Yutaka ; Kurosaki, Masayuki ; Komiyama, Yasuyuki ; Takada, Hitomi ; Tamaki, Nobuharu ; Watakabe, Keiya ; Okada, Mao ; Wang, Wan ; Shimizu, Takao ; Kubota, Yohei ; Higuchi, Mayu ; Takaura, Kenta ; Tsuchiya, Kaoru ; Nakanishi, Hiroyuki ; Takahashi, Yuka ; Itakura, Jun ; Enomoto, Nobuyuki ; Izumi, Namiki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4473-fa3334c5ca0b36174d53867e17de5f96697c8bcd022b157dd6d8f723643f39213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>alpha‐fetoprotein</topic><topic>Antiviral agents</topic><topic>chronic hepatitis C</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>Hepatocellular carcinoma</topic><topic>Interferon</topic><topic>Liver cancer</topic><topic>Multivariate analysis</topic><topic>Patients</topic><topic>Wisteria floribunda</topic><topic>Wisteria floribunda agglutinin‐positive Mac‐2 binding protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yasui, Yutaka</creatorcontrib><creatorcontrib>Kurosaki, Masayuki</creatorcontrib><creatorcontrib>Komiyama, Yasuyuki</creatorcontrib><creatorcontrib>Takada, Hitomi</creatorcontrib><creatorcontrib>Tamaki, Nobuharu</creatorcontrib><creatorcontrib>Watakabe, Keiya</creatorcontrib><creatorcontrib>Okada, Mao</creatorcontrib><creatorcontrib>Wang, Wan</creatorcontrib><creatorcontrib>Shimizu, Takao</creatorcontrib><creatorcontrib>Kubota, Yohei</creatorcontrib><creatorcontrib>Higuchi, Mayu</creatorcontrib><creatorcontrib>Takaura, Kenta</creatorcontrib><creatorcontrib>Tsuchiya, Kaoru</creatorcontrib><creatorcontrib>Nakanishi, Hiroyuki</creatorcontrib><creatorcontrib>Takahashi, Yuka</creatorcontrib><creatorcontrib>Itakura, Jun</creatorcontrib><creatorcontrib>Enomoto, Nobuyuki</creatorcontrib><creatorcontrib>Izumi, Namiki</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yasui, Yutaka</au><au>Kurosaki, Masayuki</au><au>Komiyama, Yasuyuki</au><au>Takada, Hitomi</au><au>Tamaki, Nobuharu</au><au>Watakabe, Keiya</au><au>Okada, Mao</au><au>Wang, Wan</au><au>Shimizu, Takao</au><au>Kubota, Yohei</au><au>Higuchi, Mayu</au><au>Takaura, Kenta</au><au>Tsuchiya, Kaoru</au><au>Nakanishi, Hiroyuki</au><au>Takahashi, Yuka</au><au>Itakura, Jun</au><au>Enomoto, Nobuyuki</au><au>Izumi, Namiki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus</atitle><jtitle>Hepatology research</jtitle><addtitle>Hepatol Res</addtitle><date>2018-12</date><risdate>2018</risdate><volume>48</volume><issue>13</issue><spage>1131</spage><epage>1139</epage><pages>1131-1139</pages><issn>1386-6346</issn><eissn>1872-034X</eissn><abstract>Aim The aim of this study is to clarify the value of serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein (WFA+‐M2BP) for predicting hepatocellular carcinoma (HCC) in chronic hepatitis C patients who achieved sustained virologic response (SVR) by therapy with interferon‐free, direct‐acting antivirals (DAAs). Methods This is a retrospective cohort study that included 567 patients who underwent antiviral therapy with an interferon‐free DAA regimen and achieved SVR. Serum WFA+‐M2BP was measured after SVR. Factors predictive of HCC occurrence and recurrence were analyzed in the patients after stratification by previous treatment history of HCC. Results Among 518 patients who had no history of HCC, 13 developed HCC. Post‐SVR WFA+‐M2BP ≥1.75 cut‐off index (C.O.I., P &lt; 0.001) and α‐fetoprotein (AFP) level ≥6 ng/mL (P = 0.01) were significant predictors of HCC development. Multivariate analysis showed that post‐SVR WFA+‐M2BP ≥1.75 C.O.I. was an independent factor significantly associated with the development of HCC (hazard ratio [HR] 6.0; 95% confidence interval (CI), 1.8–19.4; P = 0.003). Among 49 patients who had a previous history of HCC, 22 had recurrence after SVR. Post‐SVR AFP ≥6 ng/mL was the only factor associated with recurrence‐free survival (HR 3.1; 95% CI, 1.3–7.5; P = 0.01). Conclusions Post‐SVR WFA+‐M2BP is a predictive factor for the development of HCC in patients with no previous HCC history and treated with DAAs. Post‐SVR AFP was predictive for HCC recurrence after DAA therapy.</abstract><cop>Netherlands</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30030872</pmid><doi>10.1111/hepr.13233</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-6117-4990</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1386-6346
ispartof Hepatology research, 2018-12, Vol.48 (13), p.1131-1139
issn 1386-6346
1872-034X
language eng
recordid cdi_proquest_miscellaneous_2073323287
source Wiley Online Library Journals Frontfile Complete
subjects alpha‐fetoprotein
Antiviral agents
chronic hepatitis C
Hepatitis
Hepatitis C
Hepatocellular carcinoma
Interferon
Liver cancer
Multivariate analysis
Patients
Wisteria floribunda
Wisteria floribunda agglutinin‐positive Mac‐2 binding protein
title Wisteria floribunda agglutinin‐positive Mac‐2 binding protein predicts early occurrence of hepatocellular carcinoma after sustained virologic response by direct‐acting antivirals for hepatitis C virus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T11%3A29%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Wisteria%20floribunda%20agglutinin%E2%80%90positive%20Mac%E2%80%902%20binding%20protein%20predicts%20early%20occurrence%20of%20hepatocellular%20carcinoma%20after%20sustained%20virologic%20response%20by%20direct%E2%80%90acting%20antivirals%20for%20hepatitis%20C%20virus&rft.jtitle=Hepatology%20research&rft.au=Yasui,%20Yutaka&rft.date=2018-12&rft.volume=48&rft.issue=13&rft.spage=1131&rft.epage=1139&rft.pages=1131-1139&rft.issn=1386-6346&rft.eissn=1872-034X&rft_id=info:doi/10.1111/hepr.13233&rft_dat=%3Cproquest_cross%3E2158394851%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2158394851&rft_id=info:pmid/30030872&rfr_iscdi=true